Exsilio Therapeutics logo

Exsilio Therapeutics

Boston, MA

Exsilio's method is based on naturally occurring genetic elements that can accurately insert new genes into cells via RNA intermediate templates. Exsilio employs predictive in-silico modeling and wet lab-based experiments to create such elements for accurate insertion of therapeutic genes into safe harbor regions of disease-relevant cells.

exsiliotx.com

Company Details

Founded

2022

Employees

Between 20 - 50 employees

Raised

$82,000,000

Headquarters Location

Boston, MA

Public

No

Acquired

No

CEO

Thomas Barnes

Company Collections

These are collections Exsilio Therapeutics is a part of. Click on the collection name to view similar companies.

Exsilio Therapeutics' Industries

Exsilio Therapeutics Headquarters Location

Boston, MA 02110

Total Amount Raised: $82,000,000

Exsilio Therapeutics Funding Rounds

  • Series A

    $82,000,000

    Series A Investors

    Delos Capital
    Novartis Venture Fund
    OrbiMed Advisors
    CRISPR Therapeutics
    Insight Venture Partners
    Invus
    Innovation Endeavors
    Cushman & Wakefield
    Deep-Insight
    Deep Insight
    Arc Ventures
Funding info provided by Diffbot.

Exsilio Therapeutics Reviews

0 out of 5 stars

Based on 0 reviews

Review data

Share your thoughts

Worked here? Share your experience. Help others decide if this company is right for them. Write a review on Exsilio Therapeutics.

Recent reviews